Novavax shares jump as FDA signals path to COVID vaccine approval

• click to rate

  Posted by Two Blokes Apr 23 - Filed in Stock - 1 view
  
  Novavax, Inc. (NASDAQ:NVAX) shares surged more than 16% after the company shared a positive update on its COVID-19 vaccine, which it believes is “approvable” based on its conversations with the US Food and Drug Administration (FDA). The company said the FDA has requested additional data on the vaccine as part of a post-marketing commitment (PMC).